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Abstract 
Extravascular lung water (EVLW) is the amount of fluid that is accumulated in the interstitial and alveolar spaces. In 
lung oedema, EVLW increases either because of increased lung permeability or because of increased hydrostatic 
pressure in the pulmonary capillaries, or both. Increased EVLW is always potentially life‑threatening, mainly because it 
impairs gas exchange and reduces lung compliance. The only technique that provides an easy measurement of EVLW 
at the bedside is transpulmonary thermodilution. The validation of EVLW measurements by thermodilution was based 
on studies showing reasonable correlations with gravimetry or thermo‑dye dilution in experimental and clinical stud‑
ies. EVLW should be indexed to predicted body weight. This indexation reduces the proportion of ARDS patients for 
whom EVLW is in the normal range. Compared to non‑indexed EVLW, indexed EVLW (EVLWI) is better correlated with 
the lung injury score and the oxygenation and it is a better predictor of mortality of patients with acute lung injury 
or acute respiratory distress syndrome (ARDS). Transpulmonary thermodilution also provides the pulmonary vascular 
permeability index (PVPI), which is an indirect reflection of the integrity of the alveolocapillary barrier. As clinical appli‑
cations, EVLWI and PVPI may be useful to guide fluid management of patients at risk of fluid overload, as during septic 
shock and ARDS. High EVLWI and PVPI values predict mortality in several categories of critically ill patients, especially 
during ARDS. Thus, fluid administration should be limited when EVLWI is already high. Whatever the value of EVLWI, 
PVPI may indicate that fluid administration is particularly at risk of aggravating lung oedema. In the acute phase of 
haemodynamic resuscitation during septic shock and ARDS, high EVLWI and PVPI values may warn of the risk of fluid 
overload and prevent excessive volume expansion. At the post‑resuscitation phase, they may prompt initiation of 
fluid removal thereby achieving a negative fluid balance.
Keywords: Acute lung injury, Acute respiratory distress syndrome, Extravascular lung water, Fluid management, Fluid 
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Introduction
Extravascular lung water (EVLW) is the amount of water 
that is contained in the lungs outside the pulmonary 
vasculature. It corresponds to the sum of interstitial, 
intracellular, alveolar and lymphatic fluid, not includ-
ing pleural effusions [1]. An increase in EVLW is the 
pathophysiological hallmark of hydrostatic pulmonary 
oedema and acute respiratory distress syndrome (ARDS) 
[2]. EVLW is also high in many septic shock [3] and 
critically ill [4] patients. For many years, this variable of 
paramount importance in the pathophysiology of critical 
illness could only be measured ex vivo. The emergence of 
transpulmonary thermodilution has opened up the area 
of EVLW investigation in the clinical setting.
During recent years, many studies have been dedicated 
to EVLW in the field of critical care and ARDS research. 
They have focused on the validation of its measurement 
and on its value for the characterisation of lung oedema, 
for the prognostic stratification of critically ill patients, 
for the evaluation of lung-targeted treatments and for the 
strategy of fluid management.
We have sought to provide a comprehensive review of 
these recent advances. We also attempted to consider the 
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different clinical applications in which EVLW could help 
manage critically ill patients.
The physiology of lung water
Physiologically, there is a normal leakage of fluid and sol-
utes from the pulmonary microvessels into the pulmo-
nary interstitial tissue. Fluid and solutes do not reach the 
alveoli because of the tight junctions of the alveolar epi-
thelium. This net outward fluid filtration from microves-
sels to the interstitium is governed by Starling’s law, 
which mainly includes the gradient of hydrostatic and 
oncotic pressures between the vascular and interstitial 
spaces and the filtration coefficient of the alveolocapillary 
barrier [5–8] (Fig. 1).
To preserve their function of oxygenation, the lungs 
must be kept dry [5]. The volume of EVLW is strictly 
controlled by the lymphatic drainage system, which con-
stantly removes EVLW from the interstitial tissue and 
pours it into the superior vena cava through the thoracic 
duct. In the normal lung, the value of the normal EVLW 
indexed to the body weight (EVLWI), which results from 
the equilibrium between fluid leakage and lymphatic 
drainage, is <7  mL/kg of body weight [9]. In a series of 
534 normal lungs, Tagami and colleagues reported a 
value of EVLWI of 7.3 ± 2.8 mL/kg [10], suggesting that 
normal values of EVLWI may be <10 mL/kg.
Increased interstitial EVLW can occur as the result of 
increased pulmonary microvascular hydrostatic pressure 
or of decreased blood oncotic pressure or as the result 
of increased permeability of the alveolocapillary barrier, 
as typically in ARDS. In ARDS, the larger the increase 
in pulmonary microvascular permeability, the greater 
the outward fluid filtration from microvessels, at any 
given pulmonary microvascular hydrostatic pressure 
[7]. Also, during ARDS, if the pulmonary microvascular 
hydrostatic pressure increases, frequently occuring as 
the result of fluid resuscitation in associated circulatory 
failure, the increase in EVLW is all the more pronounced 
as impairment of pulmonary permeability increases 
(Fig. 2).
At the early stages, the increase in interstitial EVLW 
is regulated by the compensatory increase of lymphatic 
drainage. However, at high fluid filtration rate, lymphatic 
drainage is overwhelmed and interstitial EVLW enters 
the alveoli [6–8]. In hydrostatic pulmonary oedema, 
another mechanism also contributes to the protection of 
the lung against fluid overload: excess fluid is removed 
from the alveoli to the interstitial tissue across the alveo-
lar epithelial barrier by active ion transport [11, 12]. In 
ARDS, this alveolar fluid clearance is impaired and the 
lymphatic network is injured, all of which contributing to 













Fig. 1 Physiology of lung water. There is a physiological net outward fluid filtration from microvessels to the interstitium governed by the Starling’s 
law, which is strictly controlled by the lymphatic drainage system (Palv alveolar pressure, PH hydrostatic pressure, Ponc oncotic pressure, K filtration 
coefficient of the alveolocapillary barrier, Kσ reflection coefficient of the alveolocapillary barrier)
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How to measure EVLW?
In clinical practice, the positive diagnosis of pulmonary 
oedema is based on clinical examination and chest X-ray. 
Nevertheless, quantifying the volume of EVLW from 
clinical examination and chest X-ray is much more com-
plex, because of interobserver variability and the lack 
of sensitivity of this approach [13, 14]. Other methods 
are thus required to measure EVLW directly. The gold 
standard is gravimetry [15]. This ex vivo method consists 
in measuring the difference in the weight of the lungs 
before and after they have been dried out. Of course, this 
method cannot be used in living patients.
EVLW can be estimated by computed tomography 
[16] or magnetic resonance imaging [15], but such tech-
niques are not appropriate for convenient and repeated 
assessment. Isotopic methods [17] can only be used for 
research and electrical impedance tomography [18] is 
currently not sufficiently validated.
Lung ultrasonography is increasingly used to detect 
lung oedema [19]. Nevertheless, its ability to quantify the 
volume of EVLW is not established. There is no defined 
method for grading the severity of typical ultrasonogra-
phy signs of lung oedema. Moreover, ultrasonography 
may be limited by the fact that it assesses lung oedema in 
some specific regions and not in the whole organ.
As a first clinical alternative, transpulmonary thermo-
dye dilution, which can be considered as the in vivo gold 
standard for EVLWI measurement, has been developed 
and validated versus gravimetry in animals [20] and 
human beings [21]. The technique requires a central 
venous catheter inserted in the superior vena cava terri-
tory and a thermistor-tipped arterial catheter placed in 
the femoral artery. The thermo-dye dilution is performed 
by injecting simultaneously through the central venous 
catheter a cold indicator (cold saline) and a colorimet-
ric indicator (indocyanine green). The volume of distri-
bution of the cold indicator includes the intravascular 
and the extravascular spaces of the intrathoracic com-
partment, whereas the colorimetric indicator is strictly 
an intravascular indicator. Thus, the measurement of 
EVLWI is obtained by subtracting the volume of distri-
bution of these two indicators (Fig. 3). Nevertheless, this 
method is cumbersome and costly and has been advanta-
geously replaced by the transpulmonary thermodilution 
technique.
Principles of transpulmonary thermodilution
With this technique, the patient must have a central 
venous catheter in the superior vena cava territory and 
a thermistor-tipped arterial catheter, most often in the 
femoral artery. It can also be inserted in the axillary, bra-
chial and radial arteries [22]. The thermodilution meas-
urement is performed by injecting cold saline through 
the central venous catheter. The ensuing decrease in 
blood temperature is detected by the thermistor-tipped 
arterial catheter, thus yielding a thermodilution curve.
EVLWI is estimated from an analysis of the thermodi-












Fig. 2 Relationship between extravascular lung water and pulmonary capillary hydrostatic pressure for different levels of pulmonary vascular per‑
meability. The higher the lung permeability, the greater the risk of increase in extravascular lung water during volume expansion
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and Newman principles [23, 24] (Fig. 4). According to the 
Stewart–Hamilton principle, the total distribution vol-
ume of the cold indicator between the injection and the 
detection sites is obtained by multiplying cardiac output 
by the mean transit time of the cold indicator provided by 
the thermodilution curve: intrathoracic thermal volume 
(ITTV)  =  cardiac output × mean transit time (Fig.  4). 
According to the Newman principle, the largest distribu-
tion volume of the cold indicator between the injection 
and the detection sites, which is the total pulmonary vol-
ume, is obtained by multiplying cardiac output by the 
downslope time of the thermodilution curve (Fig. 4).
The measurement of EVLWI then requires two more 
steps. First, the global end-diastolic volume (GEDV), 
which is the sum of the maximal volumes of the four 
cardiac chambers, is obtained by subtracting the total 
pulmonary volume from ITTV (Fig.  4). Second, the 
intrathoracic blood volume (ITBV) is estimated from the 
GEDV according to the equation: ITBV = GEDV × 1.25 
[25, 26] (Fig.  4). The latter estimation is inferred from 
a study in which ITBV was measured by thermo-dye 
and single thermodilution [25]. From the thermo-
dye dilution measurements, the authors showed that 
ITBV and GEDV were linearly correlated and that 
ITBV = (1.25 × GEDV) − 28.4 mL. In a validation popu-
lation, the ITBV estimated through this equation from 
GEDV measured by single thermodilution was a reliable 
estimation of the ITBV measured by thermo-dye ther-
modilution [25]. This relationship between ITBV and 
GEDV has been confirmed in cardiac surgical patients 
[26]. Finally, EVLWI is obtained by subtracting ITBV 
from ITTV (Fig. 4).
Validation of EVLW estimated by transpulmonary 
thermodilution
The validity of the measurement of EVLWI by transpul-
monary thermodilution has been established and 
consolidated in recent years. EVLWI measured by 
transpulmonary thermodilution was reasonably corre-
lated with the value measured by thermo-dye dilution 
in humans [25, 27] and with the value obtained through 
gravimetry in animals [28–30]. More recently, the vali-
dation in human beings came from an autopsy study in 
which the value of EVLWI measured by transpulmonary 
thermodilution before death well correlated with the 
value obtained by gravimetry after autopsy [9].
The reliability of EVLWI estimated by transpulmonary 
thermodilution was also suggested by studies showing 
the good precision of the measurement in animals [31, 
32] and in patients [33, 34]. For instance, Dres and col-
leagues reported that transpulmonary thermodilution 
was able to detect the small and short-term changes in 
EVLWI induced by bronchoalveolar lavage [34]. The 
increase induced by the lavage that was detected by ther-
modilution was very close to the volume of saline that 
could not be removed by suction during the procedure 
and was left in the lungs.
Finally, another argument in favour of the validity of 
thermodilution for estimating EVLWI comes from stud-




















EVLW =  ITTV - ITBV
Fig. 3 Measurement of extravascular lung water by thermo‑dye dilution (MTt mean transit time)
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ill, septic and ARDS patients independently of other 
severity indices [35–38]. This indirectly validates the esti-
mation of EVLWI by transpulmonary thermodilution 
since such a prediction of mortality would be impossible 
to demonstrate if the measurement of EVLWI were not 
valid. In this study, the fact that the result could be influ-
enced by the mathematical coupling between EVLWI and 
biometric data (weight and height) that themselves influ-
ence prognosis [39] was avoided by the inclusion of these 


















ITBV = 1.25 x GEDV
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Fig. 4 Measurement of extravascular lung water by single thermal indicator dilution (MTt mean transit time, Dt downslope time)
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The issue of EVLW indexation
Historically, EVLW measurement has been indexed to 
the weight of patients at the time of the measurement 
[40]. However, the main determinant of lung volume is 
not the patient’s weight, but rather the patient’s height, 
and perhaps the gender [41]. Two recent studies have 
suggested that EVLW should be indexed to height only 
[42, 43]. Height was the only biometric parameter inde-
pendently associated with EVLW measurements [42]. 
Indexing EVLW to the weight underestimates EVLW in 
the case of overweight, a condition that is common in 
critically ill patients due to the positive fluid balance. In 
this regard, it has been observed that indexing EVLW to 
predicted body weight reduced the proportion of ARDS 
patients for whom EVLWI was in the normal range [40]. 
EVLWI was better correlated with lung injury score and 
oxygenation [40, 44] and was a better predictor of mor-
tality in acute lung injury (ALI)/ARDS patients if indexed 
to predicted rather than to actual body weight [44, 45].
Practical aspects of EVLW measurements
The values of EVLWI provided by three successive 
transpulmonary thermodilution measurements should 
be averaged. When three cold boluses are used, the least 
significant change in EVLWI is 12  % [33]. Roughly, this 
means that changes in EVLWI of more than one unit can 
be considered as significant.
Although injecting the cold bolus in the superior vena 
cava territory is the common method for transpulmonary 
thermodilution, the femoral vein could also be used [46]. 
Nevertheless, injection in the superior vena cava territory 
should be considered as the validated reference. It has 
been suggested that room temperature boluses could be 
used instead of iced ones, without changing the reliabil-
ity of transpulmonary thermodilution [47]. Nevertheless, 
a recent study suggested that room temperature boluses 
result in slight but significant overestimation of EVLWI 
[48].
Commercially available devices
The two transpulmonary thermodilution devices that are 
currently commercially available (PICCO2, Maquet®, 
Munich, Germany and VolumeView/EV 1000®, Edwards 
Lifesciences, Irvine, CA, USA) both use the Stewart–
Hamilton principle to calculate the cardiac output and 
the same algorithm to calculate EVLWI, even if they use a 
different algorithm to assess GEDV [49, 50].
Whereas the PICCO monitor assesses GEDV accord-
ing to the Newman principle, the VolumeView/EV 1000 
monitor assesses it from the maximum up-slope and 
the maximum down-slope of the thermodilution curve 
and a proprietary function [50]. An experimental study 
has shown that under different haemodynamic and 
respiratory conditions (hypovolaemia, hypervolaemia, 
inotropic stimulation, ARDS), the EVLWI measurements 
provided by both devices were comparable [49]. A more 
recent human study has confirmed that EVLWI values 
provided by these two devices are interchangeable [50].
Limitations of EVLW measurement 
by transpulmonary thermodilution
The limitations of EVLWI measurement by transpul-
monary thermodilution and the conditions in which it 
is not reliable have been better and better characterised 
(Table 1).
Pulmonary vascular occlusion
The accuracy of EVLWI measurement depends on the 
volume of distribution of the cold indicator, i.e. the ITTV. 
This means that transpulmonary thermodilution can only 
detect EVLW in lung regions that are reached by the cold 
indicator, i.e. in well-perfused areas.
In experimental studies, the occlusion of large pul-
monary arteries led to underestimation of EVLWI by 
transpulmonary thermo-dye dilution compared with 
gravimetry, which was corrected after the reopen-
ing of the arteries [51–53]. However, underestimation 
of EVLWI was observed only when large vessels were 
occluded [51, 53], not small vessels [52]. The clinical 
implication is that the value of EVLWI measured by ther-
modilution is likely underestimated in the case of pul-
monary embolism. During ARDS, the occlusions of the 
pulmonary vasculature that could result from vascular 
remodelling, microthrombi, hypoxic vasoconstriction 
or positive end-expiratory pressure (PEEP) [54] mainly 
affect the small vessels. This suggests that the accuracy of 
EVLWI measurement should not be impaired by vascular 
occlusion in this clinical instance.
Lung resection
Logically, lung resection decreases the volume of EVLW. 
Two experimental studies [55, 56] showed that EVLWI 
measurement by transpulmonary thermo-dye dilution or 
Table 1 Limitations of  extravascular lung water measure-
ment by transpulmonary thermodilution
Overestimation of extravascular lung water
 Positive end‑expiratory pressure (potential)
 Lung resection (proven)
Underestimation of extravascular lung water
 Positive end‑expiratory pressure (potential)
 Pulmonary vascular occlusion (proven)
 Heterogeneous lung injury (potential)
 Pleural effusions (plausible)
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thermodilution decreased after pneumonectomy, but was 
correlated with the gravimetric EVLWI measurement. 
Nevertheless, the absolute value of EVLWI measured by 
transpulmonary thermodilution was overestimated com-
pared with the EVLWI measurement by gravimetry [55]. 
Similarly, a recent experimental study demonstrated that 
EVLWI measurement by transpulmonary thermodilution 
was significantly affected by 1-lung ventilation [57]. Thus, 
in ARDS patients with pneumonectomy or 1-lung ven-
tilation, EVLWI measurement by transpulmonary ther-
modilution should be interpreted with caution, though 
the ability of the technique to measure changes in EVLWI 
should be unaffected.
Type of ARDS
Experimental studies have shown that EVLWI measure-
ment by transpulmonary thermodilution is correlated 
with the gravimetric measurement in a homogeneous 
lung injury indirectly induced by oleic acid, but is under-
estimated in a heterogeneous lung injury directly induced 
by hydrochloric acid [58–60]. This underestimation of 
EVLWI was attributed to a redistribution of the pulmo-
nary blood flow away from the oedematous areas.
Nevertheless, using PET scan, Schuster and col-
leagues demonstrated that in ALI/ARDS patients there 
was no difference in regional pulmonary perfusion pat-
tern with healthy subjects and that mechanisms such as 
hypoxic vasoconstriction allowing redistribution of pul-
monary blood flow away from oedematous lung regions 
were severely blunted [61]. Therefore, it can be sup-
posed that the type of ALI/ARDS would not alter the 
accuracy of EVLWI measurement by transpulmonary 
thermodilution.
PEEP
In theory, the effects of PEEP on EVLWI measurement are 
complex and result from opposite mechanisms. First, PEEP 
could alter the reliability of transpulmonary thermodilution 
by having opposite effects on the diffusion volume of the 
cold indicator. On the one hand, high levels of PEEP could 
reduce the cold indicator diffusion volume by squeezing 
pulmonary microvessels, leading to an underestimation of 
EVLWI [62]. On the other hand, high levels of PEEP could 
increase the cold indicator diffusion volume by recruiting 
some atelectatic lung regions and reducing hypoxic vaso-
constriction, leading to an overestimation of EVLWI [58].
Second, PEEP could actually change the volume of 
EVLWI through, here again, opposite mechanisms. By 
decreasing cardiac output, PEEP may reduce the pul-
monary microvascular hydrostatic pressure and hence 
EVLWI [63]. Also, during ARDS, by increasing the 
central venous pressure, PEEP could impede the lym-
phatic drainage of EVLWI [64]. By contrast, during 
hydrostatic pulmonary oedema, PEEP could contribute 
to the decrease in EVLWI by improving cardiac function 
through its own haemodynamic effects [65].
The net consequence of these theoretical mechanisms 
in clinical practice is unclear. In a study conducted in 
ARDS patients, there was a strong correlation between 
the EVLWI measured by transpulmonary thermo-dye 
dilution and the lung weight measured by computed 
tomography in a broad range of PEEP levels (from 10 
to 20 cmH2O) [16]. This may suggest that the effects of 
PEEP on EVLWI measured by transpulmonary ther-
modilution are mild or negligible. Nevertheless, we lack 
clinical studies in which all the determinants of EVLW 
formation and drainage are investigated at various levels 
of PEEP.
Pleural effusions
For many years, it has been claimed that EVLWI will be 
overestimated in the case of pleural effusions because 
the pleural fluid might contribute to the dilution of the 
cold bolus injected in the superior vena cava. Never-
theless, this is unlikely because of the distance between 
fluid in the pleural cavity and the pulmonary vasculature. 
Accordingly, an experimental study previously showed 
that pleural effusion in dogs had no effect on the values of 
EVLWI measured by double-indicator dilution technique 
[66]. Moreover, a recent clinical study reported that 
large-volume thoracentesis resulted not in a decrease, 
but in an increase in transpulmonary thermodilution-
derived EVLWI [67]. This increase in EVLWI was likely 
explained by the expansion of some atelectatic regions 
with thoracocentesis or, less likely, by the occurrence of a 
post-thoracentesis hydrostatic pulmonary oedema. Some 
other studies are needed to confirm these former results.
Other potential limitations
Renal replacement therapy could in theory affect the reli-
ability of transpulmonary thermodilution by inducing 
leakage of the cold indicator between the injection site 
and the arterial thermometer. However, the flow of the 
extracorporeal circuit is likely not enough to be signifi-
cant. This has been clearly shown by two studies [68, 69], 
including one in which the flow rate of blood pump dur-
ing continuous veno-venous hemofiltration was as high 
as 300 mL/min [69].
Of course, transpulmonary thermodilution is not reli-
able under extracorporeal membrane oxygenation. Ther-
apeutic hypothermia likely does not affect the drift in 
blood temperature induced by cold bolus injection, what 
explains why transpulmonary thermodilution measure-
ment of EVLWI is reliable in this situation [70].
The complications inherent to transpulmonary ther-
modilution technique are in fact related to the venous 
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and arterial catheterisations [71]. In particular, the arte-
rial catheter is of larger diameter than common arterial 
cannula, because it includes a thermistor. Nevertheless, 
in a multicentre review of 514 catheters, the incidence 
of limb ischemia and femoral artery thrombosis was rare 
(0.4 and 0.2 %, respectively) [71]. Although the radial and 
axillary arteries could be used for arterial cannulations 
with specific models of catheters, these routes are less 
convenient than the femoral one.
Finally, the thermistor-tipped arterial catheter required 
for transpulmonary thermodilution costs around 200 
euros. No cost–benefit study has already been performed 
in this domain.
The pulmonary vascular permeability index
In addition to EVLWI, transpulmonary thermodilu-
tion is a unique method for estimating the permeability 
of the pulmonary capillary barrier through calculation 
of the PVPI. It is the ratio between EVLWI and pulmo-
nary blood volume [2, 72, 73], i.e. the ratio between the 
volume of fluid that has leaked toward the extravascular 
spaces and the volume of fluid that has remained in the 
intravascular compartment. The PVPI is automatically 
provided by the transpulmonary thermodilution system 
each time a cold bolus is injected.
It is of importance to note that the PVPI automatically 
displayed by the PiCCO device is reliable only when the 
central venous catheter is inserted in the superior vena 
cava territory [74]. Whether the central venous catheter 
is inserted in the femoral vein, the PVPI displayed will 
be underestimated [74]. Indeed, PVPI is indirectly cal-
culated from the GEDVI, which is overestimated in case 
of femoral venous access due to the additional volume of 
vena cava inferior participating in transpulmonary ther-
modilution [74]. While the PiCCO device automatically 
corrects GEDVI in the case of femoral venous access, this 
correction is not yet used for the calculation of PVPI [74].
The value of PVPI has been validated by some animal 
[28] and human [2, 72, 73] studies showing that it was 
significantly higher in patients with ALI/ARDS than in 
patients with hydrostatic pulmonary oedema. In a series 
of patients with pulmonary oedema, a PVPI value of 3 
was the best threshold to distinguish between both forms 
of pulmonary oedema [2, 72] and should thus be consid-
ered as the maximal normal value. Although PVPI is an 
indirect estimation of lung permeability, it is the only way 
to evidence an injury of the alveolocapillary barrier and 
to quantify the pulmonary leak at the bedside.
The prognostic value of EVLW and PVPI
EVLWI and PVPI have been shown to predict mortal-
ity in diverse categories of critically ill patients (Table 2). 
EVLWI predicted mortality in severe sepsis or septic 
shock [3, 73, 75, 76], but also in burned patients [77] 
and in a general population of critically ill patients [4]. 
In some of these studies, EVLWI was shown to predict 
mortality independently of other markers of disease [75, 
78]. Some of these studies were included in a meta-anal-
ysis, which confirmed this prognostic value of EVLWI in 
critically ill patients [79]. In the context of severe sepsis 
Table 2 Prognostic value of extravascular lung water in critically ill patients
ARDS: acute respiratory distress syndrome, EVLWI: indexed extravascular lung water, ICU: intensive care unit, MODS: multiple organ dysfunction syndrome
Study Number of  
patients
Type of EVLW indexation Prognostic value
General critically ill patients Sakka et al. [4] 373 Actual body weight Independent predictor of ICU 
mortality
Severe sepsis or septic  
shock patients
Martin et al. [3] 29 Actual body weight Higher EVLWI in ICU non‑survivors
Chung et al. [75] 33 Actual body weight Independent predictor of in‑
hospital survival
Chung et al. [76] 67 Actual body weight Independent factor for the devel‑
opment of MODS
Chew et al. [73] 51 Actual and predicted body 
weight
Higher EVLWI in ICU non‑survivors
Mallat et al. [78] 55 Actual and predicted body 
weight
Independent predictor of ICU 
mortality
ARDS patients Philips [85] 59 Actual and predicted body 
weight
Good predictor of ICU mortality
Craig et al. [45] 44 Predicted body weight Independent predictor of ICU 
mortality
Brown et al. [37] 59 Predicted body weight Independent predictor of ICU 
mortality
Jozwiak et al. [36] 200 Predicted body weight Independent predictor of Day‑28 
mortality
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or septic shock, PVPI has also been shown to be signifi-
cantly higher in non-survivors than in survivors [73, 78].
In the specific clinical setting of ARDS, it has also been 
repeatedly observed that high values of EVLWI are sig-
nificantly associated with mortality [35–37, 44, 45, 80]. 
Decrease in EVLWI during the first 48  h of ARDS may 
be associated with 28-day survival [38]. EVLWI has been 
shown to be a good predictor of mortality [36, 37, 44, 
45]. In 200 ARDS patients, our group reported that the 
maximum value of EVLWI recorded during the course 
of ARDS, but not the value of EVLWI at day-1 pre-
dicted day-28 mortality in an independent manner [36]. 
It is noteworthy that the maximum value of EVLWI was 
reached within 3 days on average [36].
It is interesting to note that EVLWI and indices of oxy-
genation have both been reported to be independent 
predictors of ARDS [36]. This suggests that both mark-
ers have their own physiological meaning. Poor oxygena-
tion in ARDS results not only from EVLW accumulated 
in the alveoli and interstitium, but also from some other 
abnormalities such as atelectasis or arteriovenous shunts 
due to pulmonary vascular injury [54]. This suggests that 
both oxygenation indices and EVLWI should be evalu-
ated to assess the severity of ARDS.
PVPI was also found to be related to the prognosis of 
ARDS patients [36, 80] and to predict mortality in an 
independent manner [36]. Both PVPI and EVLWI predict 
mortality in an independent way, which again suggests 
that they indicate a different pathophysiological pattern 
of ARDS. While PVPI appears to characterise the degree 
of impairment of the alveolocapillary barrier itself, 
EVLWI seems to indicate the severity of the pulmonary 
leak resulting from this injury.
How to use EVLW and PVPI in clinical practice?
Definition of ARDS
Neither EVLWI nor PVPI measurements have been 
included in the new Berlin definition of ARDS [81], due 
to concerns of availability [82]. However, several authors 
have suggested that, as pathophysiological hallmarks of 
ARDS, EVLWI and/or PVPI should be taken into account 
when defining the disease [83–85]. EVLWI and PVPI 
may potentially improve the definition of ARDS, as is 
suggested by at least three arguments.
First, an increase in pulmonary vascular permeabil-
ity is fundamentally the functional hallmark of ARDS. 
In the Berlin definition of ARDS, impaired permeabil-
ity is defined by the absence of high left ventricular fill-
ing pressure. However, this criterion is very indirect. 
Moreover, an increased left ventricular preload cannot 
exclude ARDS, since authentic ARDS may be accompa-
nied by high filling pressure of the left ventricle, espe-
cially if the patient has been already resuscitated. In this 
regard, some clinical studies report that the left ventricu-
lar preload is actually high in not less than one-third of 
ARDS patients [86].
Second, it was recently found that among all patients 
who met the Berlin definition of ARDS, only 45  % had 
diffuse alveolar damage [87], while this is the pathologi-
cal characteristic of ARDS. By contrast, in another study, 
an increase of EVLWI above 15 mL/kg identified patients 
with diffuse alveolar damage with 99 % certainty [10].
Third, some clinical studies directly suggest that tak-
ing EVLWI and/or PVPI values into account may help 
define ARDS and predict its prognosis. For instance, 
EVLWI predicted the progression to ALI in patients with 
risk factors 2.6 ± 0.3 days before the patients met Amer-
ican-European Consensus Conference criteria of ARDS 
[88]. In another study, the value of EVLWI was in close 
relationship with the severity of ARDS as defined by the 
categories of the Berlin definition [89]. It has also been 
shown that the use of EVLWI improves up to eightfold 
the post-test odds ratio for the diagnosis of ALI, ARDS 
and severe lung injury [73]. Even though these arguments 
plead in favour of the inclusion of EVLWI in the defini-
tion of ARDS, its value should be investigated by large-
scale studies.
Fluid management
It is today acknowledged that excessive fluid loading is 
associated with a higher risk of dying in several categories 
of patients. The cumulative fluid balance is an independ-
ent predictor of mortality in patients with septic shock 
[90], ARDS [36, 91] and acute kidney injury [92]. Like-
wise, a restrictive fluid strategy significantly reduces the 
duration of ventilation of ARDS patients [93]. In a ret-
rospective series of ARDS patients, a negative fluid bal-
ance was found to be associated with decreased EVLWI 
during the first week after admission to the intensive 
care unit (ICU) and with a decrease of day-28 mortality 
[35]. The consistent results emerging from these studies 
are explained by the deleterious pleiotropic effects of tis-
sue swelling [94], the most important being worsening of 
lung oedema.
However, fluid administration is the most widely 
used first-line treatment in acute circulatory failure. It 
is expected to increase cardiac preload and, in the case 
of preload dependence, to increase cardiac output and 
eventually improve tissue oxygenation [95]. Thus, every 
day in the ICU, clinicians have to face this therapeutic 
dilemma: for this patient with circulatory failure and lung 
impairment, should I opt for fluid administration?
Two considerations may help answer this question at 
the bedside. First, indices that have been developed to 
predict fluid responsiveness/unresponsiveness may be 
very useful [96]. If negative, they identify cases where 
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fluid administration has no chance of having any haemo-
dynamic benefits and should definitely be avoided. 
Second, EVLWI and PVPI may be used as criteria indi-
cating the risk of fluid administration. A high EVLWI 
value indicates that lung oedema is already present and 
should obviously not be worsened. Whatever the level 
of EVLWI, an increased PVPI indicates the presence of 
a pulmonary leak and that any further fluid administra-
tion is particularly at risk of increasing EVLWI (Fig.  2). 
During the acute phase of resuscitation, high EVLWI 
and PVPI may serve as indicators for fluid restriction and 
encourage clinicians to choose alternative interventions 
for haemodynamic resuscitation. After initial haemo-
dynamic stabilisation, during the de-escalation phase, 
EVLWI may be helpful in instituting an aggressive but 
controlled fluid removal strategy.
Supporting this, in the context of ARDS, some small 
studies suggest that management based on protocols 
including EVLWI measurements is safe [97], leads to a 
lower cumulative fluid balance [98], improves ICU mor-
tality [97], and reduces the duration of mechanical ven-
tilation [98] and of ICU stay [98, 99]. Nevertheless, a 
pivotal randomised trial comparing haemodynamic and 
fluid based on the values of EVLWI versus non-EVLWI-
guided therapy in ARDS or septic patients is necessary to 
confirm the results of these small studies. In this regard, 
an ongoing large-scale prospective study in ARDS is 
comparing a fluid management therapy based on central 
venous pressure and urine output with a strategy based 
on the values of EVLWI and indicators of preload reserve 
(HEAL Study, NTC00624650).
The value of guiding the therapeutic strategy by meas-
uring EVLWI has been investigated in clinical settings 
other than ARDS. After subarachnoid haemorrhage 
managed by transpulmonary thermodilution with an 
algorithm including EVLWI, patients had a lower rate 
of vasospasm and cardiopulmonary complications com-
pared with those managed with standard therapy [100]. 
In patients undergoing cardiac surgery, therapeutic algo-
rithms including EVLWI in addition to other transpul-
monary thermodilution indices also yield some clinical 
benefits [101, 102]. EVLWI was also found to be useful in 
guiding fluid removal in patients with renal replacement 
therapy [103].
Weaning from mechanical ventilation
One of the main causes of weaning failure is cardiac 
failure induced by the transfer from positive to negative 
pressure ventilation [104]. For decades, the diagnosis of 
weaning-induced pulmonary oedema has been based on 
the measurement of pulmonary artery occlusion pressure 
with the pulmonary artery catheter [105], which nowa-
days is much less used than in the past [106].
Recently, our group investigated the ability of EVLWI 
measured by transpulmonary thermodilution to evidence 
pulmonary oedema in this specific context. We showed 
that an increase in EVLWI by more than 14  % between 
the beginning and end of a T-tube weaning trial was able 
to diagnose weaning-induced pulmonary oedema with a 
sensitivity of 67 % and a specificity of 100 % [107]. In our 
opinion, these results should not encourage the inser-
tion of a transpulmonary thermodilution device for the 
sole purpose of evidencing cardiac dysfunction in a dif-
ficult-to-wean patient, since less costly and less invasive 
methods are available [108]. Rather, we suggest that, if a 
transpulmonary thermodilution device is still in place at 
the time of weaning from mechanical ventilation, atten-
tion should be paid to the changes in EVLWI during the 
spontaneous breathing trials.
Other potential clinical situations
In lung transplantation, the major criterion currently 
used to evaluate the viability of pulmonary grafts before 
transplantation is the ratio between partial pressure of 
arterial oxygen and the fraction of inspired oxygen [109]. 
Nevertheless, this criterion might be insufficient for ade-
quate assessment of the suitability of lungs for transplan-
tation [109]. Three recent studies [110–112] have shown 
that EVLWI measured by transpulmonary thermodilu-
tion could be a useful parameter in this context. It is able 
to assess pulmonary oedema during ex vivo lung perfu-
sion [112] and in potential lung donors [111]. Moreo-
ver, it predicts the suitability of the pulmonary grafts for 
transplantation [110, 111].
EVLWI and PVPI may also be used to assess the effects 
of some specific therapeutic interventions during ARDS. 
For instance, the effects of prone positioning on EVLWI 
have been investigated. While one study reported that 
EVLWI does not change to a relevant extent 10 min [113] 
or up to 6 h after prone positioning [114], another study 
found that it significantly decreased after 18  h in prone 
position [115]. This suggests that EVLWI may follow the 
improvement of the other markers of pulmonary func-
tion during the postural manoeuvre, even though these 
observations need to be confirmed. Data are lacking to 
explain the pathophysiological mechanisms underlying 
these potential changes. For instance, the degree of asso-
ciation between lung recruitment induced by prone posi-
tioning and the level of EVLWI has not been investigated.
Conclusions
Transpulmonary thermodilution has emerged as the 
technique allowing clinicians to estimate the volume 
of lung oedema at the bedside. PVPI, which is derived 
from the EVLWI measurement, is an indirect marker 
of the permeability of the alveolocapillary barrier. In 
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spite of some limitations, measurements of EVLWI and 
PVPI should now be considered as accurate and pre-
cise. As clinical applications, measuring EVLWI quanti-
fies pulmonary oedema and PVPI distinguishes between 
hydrostatic and permeability lung oedema. A large-scale 
study should confirm the utility of including EVLW and 
PVPI in the common management of ARDS. EVLWI 
and PVPI may contribute to a better definition of ARDS, 
even though this still needs to be. EVLWI and PVPI 
may mostly be used to conduct fluid resuscitation in a 
safe and controlled manner, especially in septic shock 
combined with ARDS. High EVLWI and PVPI values 
may indicate that further fluid administration risks fluid 
overload and, at the post-acute phase, that fluid removal 
should be initiated.
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